Evidence map›Paper›PMID 30707846›Full record

ArticlePharmaceutical biology2019

Anti-inflammatory and anti-osteoarthritis effect of Mollugo pentaphylla extract.

Yun Mi Lee, Eunjung Son, Seung-Hyung Kim, Ohn Soon Kim, Dong-Seon Kim

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Network analysis,Frontiers in pharmacology · 2023
    Article
  7. Article
  8. Effects ofIranian journal of pharmaceutical research : IJPR · 2022
    Article
  9. Research in pharmaceutical sciences · 2022
    Article
  10. Article
  11. Natural Approach in Osteoarthritis Therapy.Recent advances in inflammation & allergy drug discovery · 2022
    Review
  12. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Beneficial effects ofFood science & nutrition · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yun Mi Leea Herbal Medicine Research Division , Korea Institute of Oriental Medicine , Daejeon , South Korea.
Eunjung Sona Herbal Medicine Research Division , Korea Institute of Oriental Medicine , Daejeon , South Korea.
Seung-Hyung Kimb Institute of Traditional Medicine and Bioscience, Daejeon University , Daejeon , South Korea.
Ohn Soon Kima Herbal Medicine Research Division , Korea Institute of Oriental Medicine , Daejeon , South Korea.
Dong-Seon Kima Herbal Medicine Research Division , Korea Institute of Oriental Medicine , Daejeon , South Korea.
Korea Institute of Oriental Medicine · KRDaejeon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextMollugo pentaphylla L. (Molluginaceae) extract (MPE) has been reported to have anti-inflammatory effect on MSU-induced gouty arthritis in a mouse model.

objectiveThis study examined the anti-inflammatory activities of an MPE in vitro and anti-osteoarthritis effects on monosodium iodoacetate (MIA)-induced osteoarthritis (OA) in vivo. MATERIALS AND

methodsThe dried whole plants of M. pentaphylla were extracted with 70% ethanol under reflux. The anti-inflammatory effect of MPE was evaluated in vitro in lipopolysaccharide (LPS)-treated RAW264.7 cells. The anti-osteoarthritic effect of MPE was investigated in a Sprague-Dawley rat model of MIA-induced OA. Each seven male rats were orally administered MPE (75, 150 or 300 mg/kg) or the positive control drug indomethacin (1 mg/kg) 3 days before MIA injection and once daily for 11 days thereafter. After the treatment with MPE, no evidence of systemic adverse effects was observed in any study group.

resultsMPE exhibited anti-inflammatory activity via inhibition of the production of NO (57.8%), PGE2 (97.1%) and IL-6 (93.2%) in LPS-treated RAW264.7 cells at 200 μg/mL. In addition, MPE suppressed IL-1β (60.9%), TNF-α (37.9%) and IL- 6 (40.9%) production and suppressed the synthesis of MMP-2, MMP-9 and COX-2 in the MIA-induced OA rat model.

conclusionsThese results demonstrate that MPE exerts potent anti-inflammatory activities and protects cartilage in an OA rat model. This might be a potential candidate for therapeutic OA treatment.

Indexed as

AnimalsAnti-Inflammatory AgentsChondrocytesIndomethacinKnee JointLipopolysaccharidesMaleMiceMolluginaceaeOsteoarthritisPlant ExtractsRandom AllocationRatsRats, Sprague-DawleyRAW 264.7 CellsWeight-BearingAnti-Inflammatory AgentsIndomethacinLipopolysaccharidesPlant ExtractscartilageinflammationOsteoarthritispain

Identifiers

PMID30707846
PMCPMC8871616
OpenAlexW2914278534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.